arrow
C

Christine Solbach

University Hospital
H指数:46
被引数:1.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

AGO Breast Committee recommendations for the surgical therapy of breast cancer: Working Group on Gynecologic Cancers (AGO) update 2026

AGO乳腺癌委员会关于乳腺癌手术治疗的建议:妇科肿瘤工作组(AGO)2026年更新

2026-05-060
OAAI
Optimization of Ki67 digital image analysis in breast cancer by automated tumor area identification

乳腺癌中通过自动肿瘤区域识别优化Ki67数字图像分析

2026-04-230
OAAI
Tumor mutations predict HER2-targeted therapy resistance in primary HER2-positive breast cancer

肿瘤突变预测原发性HER2-positive乳腺癌HER2-targeted治疗耐药

2026-04-140
OAAI
Obesity- and tumor-derived signals drive cancer-associated state transitions in breast mesenchymal stromal/stem cells reprogrammed by IL1RA or JAK inhibition

肥胖和肿瘤衍生的信号驱动经IL1RA或JAK抑制重编程的乳腺间充质基质/干细胞发生癌相关状态转变

2026-02-050
OA
Distant disease-free survival as a surrogate endpoint for overall survival in randomised trials of neoadjuvant therapy for early breast cancer: a pooled analysis of GBG and AGO-B Study Group trials

远处无病生存期作为早期乳腺癌新辅助治疗随机试验中总生存期的替代终点:GBG和AGO-B研究组试验的合并分析

2025-11-240
PRE
National policies for screening and early detection of breast cancer around the globe: Practices, barriers, and solutions

全球乳腺癌筛查与早期诊断的国家政策:实践、障碍与解决方案

2025-10-010
OAAI
AGO Breast Commission recommendations for the surgical therapy of breast cancer: Working Group on Gynecologic Cancers (AGO) update 2025

AGO乳腺癌委员会关于乳腺癌手术治疗的建议:妇科肿瘤工作组(AGO)2025年更新

2025-09-170
PREAI
Effects of pregnancy on breast cancer immunology: immune biomarker and TIL quantification

妊娠对乳腺癌免疫学的影响:免疫生物标志物和TIL量化

2025-05-140
OA
Best Practice Guidelines - DEGUM Recommendations on Breast Ultrasound - Part III/2 - Special Clinical Indications (Mar, 10.1055/a-2487-5111, 2025)
2025-03-010
PRE
Best Practice Guidelines - DEGUM Recommendations on Breast Ultrasound - Part III/1 - Special Clinical Indications (jan, 10.1055/a-2481-6610, 2025)
2025-03-010
PRE
Radar reflectors for marking of target lymph nodes in initially node-positive patients receiving neoadjuvant chemotherapy for breast cancer-a subgroup analysis of the prospective AXSANA (EUBREAST-03) trial
2025-02-200
PRE
Best Practice Guidelines - DEGUM Recommendations on Breast Ultrasound
2025-01-141
PRE
Molecular adaptation to neoadjuvant immunotherapy in triple-negative breast cancer
2024-11-010
OAAI
Neoadjuvant chemotherapy in inflammatory breast cancer: A meta-analysis of 10 trials of the German Breast Group (GBG)

炎性乳腺癌的新辅助化疗:德国乳腺癌组(GBG)10项试验的Meta分析

2024-09-010
PRE
GAIN2 trial overall survival with intense versus tailored dose dense chemotherapy in early breast cancer
2024-07-300
OAAI